PSK5 COST-UTILITY ANALYSIS OF AMEVIVE TM (ALEFACEPT) IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS
May 1, 2005, 00:00
10.1016/S1098-3015(10)62869-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)62869-0/fulltext
Title :
PSK5 COST-UTILITY ANALYSIS OF AMEVIVE TM (ALEFACEPT) IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62869-0&doi=10.1016/S1098-3015(10)62869-0
First page :
Section Title :
Open access? :
No
Section Order :
306